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Kathryn B. Garber1,*TGF-b Signaling in the Balance
The discovery of excessive TGF-b signaling in Marfan
syndrome has been an unexpected turn of events in our
understanding of this disorder and has led to clinical trials
that aim to turn down this pathway with the hope of
influencing disease progression. Paradoxically, however, in-
activating mutations in TGFBR1 and TGFBR2, the genes
encoding the TGF-b receptors, cause Loeys-Dietz syndrome,
which shares many features with Marfan syndrome. This
begs the question: how could turning up and turning
down the same signaling pathway result in similar
outcomes? The recent discovery of a novel and related
disorder suggests a resolution to this paradox. Groups led
by Dianna Milewicz and by Bart Loeys and Hal Dietz have
uncovered mutations in TGFB2 as a cause of thoracic aortic
aneurysms. Although many of the mutations, including
some full genedeletions, arehaploinsufficient, theyareasso-
ciated with increased TGF-b2 expression and signaling.
Further, Lindsay et al. found that Tgfb2 haploinsufficiency
exacerbated aortic dilatation in a mouse model of Marfan
syndrome, arguing that the two mutations contribute to
the same pathogenic mechanism. The likely explanation
for this seeming paradox is a model in which reduced func-
tionofa componentof theTGF-b-signalingpathway leads to
an excessive compensatory TGF-b-signaling increase that is
at the heart of Marfan, Loeys-Dietz, and related syndromes.
Boileau et al. (2012). Nat Genet. 44, 916–921.
Lindsay et al. (2012). Nat Genet. 44, 922–927.
Separating True Mutations from Sequence Artifacts
Next-generation sequencinghas a substantiallyhigher error
rate than does traditional Sanger sequencing, and this fact
must be managed in the analysis of genomes. Particularly
when one is looking for a rare mutation in a DNAmixture,
sequence changes that are detected by next-generation
sequencing are muchmore likely to be a result of technical
artifacts than of truemutations in theDNA sample. Schmitt
et al. figured that they could circumvent this problem by
using a naturally occurring check of the DNA sequence:
the complementary DNA strand. True mutations, they
reasoned, would be present as complementary changes in
the two strands of DNA. Although other technologies
have assessed sequence in the forward and reverse direc-
tions, Schmitt et al. came up with a way to tag the paired
strands before any other manipulations, meaning that
they can control for errors that occur from the first round1Department of Human Genetics, Emory University School of Medicine, Atlan
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The Americanof amplification and beyond. To do this, they ligated
sheared, double-stranded DNA with distinct randomized
tag sequences on each end. The DNA can then be amplified
and sequenced, and the tag sets can be used for identifying
the related DNA strands. In experiments using M13 DNA,
this approach (compared to more standard approaches to
sequence analysis) has drastically reduced the estimated
mutation frequency and brings this frequency in line with
what has been established experimentally for M13. In
a mixing experiment, duplex sequencing can accurately
detect one mutant sequence per 10,000 wild-type mole-
cules. In a human genetics context, this type of approach
could be useful for assessment of DNA mixtures including
mitochondrial DNA—something that is explored by the
authors—or somatic mosaicism.
Schmitt et al. (2012). ProcNatl Acad SciUSA. Published online
August 1, 2012. http://dx.doi.org/10.1073/pnas.1208715109.
Play On
Because of the risk of cardiac arrhythmia and sudden death,
individuals with long QT syndrome might be advised to
discontinue participation in sports. In the United States,
this recommendation is based on the patient’s long QT
interval, as well as whether the patient has an implantable
cardioverter defibrillator or symptoms due to a long QT.
European guidelines are even more strict and are solely
based on a long QT interval. Johnson and Ackerman
wondered what the outcomes were in patients who chose
to voluntarily ignore these recommendations and continue
sports participation. They had outcome information on
a total of 130 competitive athletes with long QT syndrome;
70 were competing within the United States guidelines but
contrary to European guidelines, and 60 were participating
contrary to both guidelines. Over a mean follow-up period
of 5.1 years, only one sports-related event was recorded,
and this was in a boy with an extreme QT interval and
a history of cardiac arrest. Overall, this is equal to one
sports-related event in 331 athlete years, which at least
provides families with an estimate of sports-related risks.
Johnson and Ackerman. (2012). JAMA. Published online
July 21, 2012. http://dx.doi.org/10.1001/jama.2012.9334.
Who, Which, Why?
Although the key gene that is mutated in classic familial
adenomatous polyposis is APC, not all individuals with
APC mutations have classic polyposis with more thanta, GA 30322, USA
y of Human Genetics. All rights reserved.
Journal of Human Genetics 91, 401–402, September 7, 2012 401
100 adenomas. Overlapping in the phenotypic spectrum
of APC mutations are cases of colorectal adenomas due to
recessive mutations in MUTYH, and some people with
multiple adenomas have mutations in neither gene. In
a group of individuals with these adenomas, then, how
can one tell which gene to analyze and in whom? To tackle
this issue, Grover et al. related themutation frequencies for
both genes to phenotype in a sample of more than 8,000
individuals with multiple colorectal adenomas. Although
as might be expected, APC mutations were increasingly
common as the number of adenomas increased, and as
the age of diagnosis of adenomas decreased, the prevalence
ofMUTYHmutations was lower and fairly constant relative
to adenoma count. The authors developed a multinomial
logistic regression model that can be used for assessing
the probability of finding a mutation in either gene
on the basis of an individual’s phenotype and family
history. Unfortunately, even if everybody with colorectal
adenomas received genetic testing for APC and MUTYH,
a significant fraction of inherited risk for this condition
would still not be detected. In this cohort, 18% of individ-
uals with 1,000 or more adenomas—by definition, classic
polyposis—had a mutation in neither APC nor MUTYH.
When it comes to adenomas, this analysis does provide
some guidance as to who should be sequenced and for
which genes, but this is far from cut and dried.
Grover et al. (2012). JAMA 308, 485–492.402 The American Journal of Human Genetics 91, 401–402, SeptembCiliopathy Due to Defect in DNA-Damage Response
Although the primary cilium is not a cellular organelle
that most of us learned much about in biology class,
increasing amounts of data over the last few years have
given cilia much more prominence. Mutations in many
different components of this structure, as well as in those
that assemble the structure, lead to a class of disorders
known as ciliopathies, which tend to manifest as groups
of symptoms that can include retinal dysfunction, renal
problems, brain malformations, and others. One of
the ciliopathy phenotypes is nephronopthisis, a kidney
disease that can be attributed to mutations in several
genes related to cilia. Even so, a significant fraction of
nephronopthisis cases cannot be explained by known
ciliary components, leading Chaki et al. to use a com-
bination of homozygosity mapping and exome sequenc-
ing to find novel causes of this phenotype. Lo and
behold, this approach has led them to link this ciliopathy
to a new function: DNA-damage repair. They found
nephronopthisis-associated mutations in three separate
genes that all function in the DNA-damage-response
pathway and confirmed their association with the ciliop-
athy phenotypes via knockdown experiments in zebrafish.
I, for one, am starting to think of cilia as cellular tentacles
that reach into many different and interesting aspects of
biology.
Chaki et al. (2012). Cell 150, 533–548.This Month in Our Sister JournalATriplet Expansion You Might Actually Want to Have
From autism to congenital heart disease, copy-number
variation at the cytogenetically complex segment of chro-
mosomal region 1q21 has been implicated in a range of
phenotypes. Within this genomic segment is a repeated
element encoding the DUF1220 protein domain, whose
copy number has expanded specifically in the human
lineage. In recent work published in G3, Jim Sikela’s group
described the evolutionary history of DUF1220 domains.
They define six clades of DF1220 sequences and report
that the hyperamplification of this domain is restricted
to a specific tandemly repeated triplet of DUF1220
sequences. Although this triplet arrangement is present
in the chimp and gorilla genomes, its expansion is unique
to humans; this might be due to the fact that this chromo-
somal region contains other human-specific features,
including a pericentric inversion from 1p11.2-q21.2 and
a polymorphic expansion of heterochromatin. Beyondits human-specific evolutionary structure, though, does
the expansion of this domain have anything to do with
what makes humans unique? In this issue of AJHG,
another paper by Jim Sikela’s group suggests that maybe
it does. They used high-density comparative genomic
hybridization arrays to zero in on the individual com-
ponents of chromosomal region 1q21. This analysis
implicates DUF1220 copy number in determining human
brain size and suggests that reductions in DUF1220 copy
number are at the heart of microcephaly due to deletions
at chromosomal region 1q21. Conversely, increases in
DUF1220 copy number are correlated with macrocephaly
due to duplications in the same region. Thus, as this
genomic segment expanded, so might have the human
brain.
O’Bleness et al. (2012). G3 (Bethesda) 2, 977–986.
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